A Credibility Assessment Plan for an In Silico Model that Predicts the Dose–Response Relationship of New Tuberculosis Treatments

Tuberculosis is one of the leading causes of death in several developing countries and a public health emergency of international concern. In Silico Trials can be used to support innovation in the context of drug development reducing the duration and the cost of the clinical experimentations, a part...

Descripción completa

Detalles Bibliográficos
Autores principales: Curreli, Cristina, Di Salvatore, Valentina, Russo, Giulia, Pappalardo, Francesco, Viceconti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
S.I. : Modeling for Advancing Regulatory Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483464/
https://www.ncbi.nlm.nih.gov/pubmed/36115895
http://dx.doi.org/10.1007/s10439-022-03078-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483464/
https://www.ncbi.nlm.nih.gov/pubmed/36115895
http://dx.doi.org/10.1007/s10439-022-03078-w

Ejemplares similares